Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Top 5 Marijuana Stocks for 2019
With individual stock selection now more critical than ever, this report is designed to bring you some of our top ideas in the marijuana industry this year.
One of the companies highlighted in this report offers a life-changing therapy that reduces the number of seizures in children with two rare types of childhood-onset epilepsy. It has the potential for the stock to sky-rocket. You need to find out the name of this company before the rest of the market does.
P.S. Not many retail investors pay attention to the marijuana sector. Use this complimentary guide and get a head start on your path to profiting from the booming cannabis industry!
Menu

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,008,057
  • Shares Outstanding, K 241,162
  • Annual Sales, $ 16,100 K
  • Annual Income, $ -132,620 K
  • 60-Month Beta 2.06
  • Price/Sales 63.51
  • Price/Cash Flow N/A
  • Price/Book 10.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.17
  • Number of Estimates 5
  • High Estimate -0.15
  • Low Estimate -0.18
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.12 +0.93%
on 04/23/19
5.26 -20.94%
on 03/25/19
-1.03 (-19.88%)
since 03/22/19
3-Month
4.12 +0.93%
on 04/23/19
6.09 -31.72%
on 03/04/19
-1.10 (-20.94%)
since 01/24/19
52-Week
3.51 +18.64%
on 12/21/18
7.66 -45.71%
on 06/08/18
-1.45 (-25.88%)
since 04/24/18

Most Recent Stories

More News
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners

--Additional Non-Dilutive Funding Will Support the Launches of BIJUVA(TM) and ANNOVERA(TM)

TXMD : 4.14 (-0.96%)
TherapeuticsMD Announces Commercial Availability of BIJUVA(TM) in the U.S.

---Company to Hold Investor Day in New York on Monday, June 10, 2019-

TXMD : 4.14 (-0.96%)
Therapeuticsmd Falls 3.08% on Heavy Volume: Watch For Potential Rebound

Therapeuticsmd (NASDAQ:TXMD) traded in a range yesterday that spanned from a low of $5.03 to a high of $5.17. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $5.21...

TXMD : 4.14 (-0.96%)
TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA(TM) and ANNOVERA(TM) at the Endocrine Society 2019 Annual Meeting

--One Oral Presentation and One Poster Will Present ANNOVERA Phase 3 Data About Antiovulatory Effects and Impact on Lipids and Hepatic Proteins

TXMD : 4.14 (-0.96%)
24.7% Return Seen to Date on SmarTrend Therapeuticsmd Call (TXMD)

SmarTrend identified an Uptrend for Therapeuticsmd (NASDAQ:TXMD) on January 7th, 2019 at $4.44. In approximately 2 months, Therapeuticsmd has returned 24.69% as of today's recent price of $5.53.

TXMD : 4.14 (-0.96%)
First Week of TXMD May 17th Options Trading

Investors in TherapeuticsMD Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TXMD options chain for...

TXMD : 4.14 (-0.96%)
TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the schedule of oral presentations on clinical data for BIJUVA(TM) (estradiol and progesterone...

TXMD : 4.14 (-0.96%)
Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of TherapeuticsMD, Inc. (NASDAQ:TXMD),...

BGNE : 119.26 (-1.53%)
NDSN : 148.22 (+0.07%)
CRAY : 27.03 (-1.17%)
ESV : 17.15 (-0.41%)
GPS : 25.71 (+2.63%)
TXMD : 4.14 (-0.96%)
TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that the company will participate in two upcoming healthcare conferences. Chief Executive...

TXMD : 4.14 (-0.96%)
After Yesterday's Rally of 5.51% Shares Could Potentially Pullback

Therapeuticsmd (NASDAQ:TXMD) traded in a range yesterday that spanned from a low of $5.50 to a high of $5.74. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $5.61...

TXMD : 4.14 (-0.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade TXMD with:

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

2nd Resistance Point 4.37
1st Resistance Point 4.27
Last Price 4.14
1st Support Level 4.10
2nd Support Level 4.03

See More

52-Week High 7.66
Fibonacci 61.8% 6.07
Fibonacci 50% 5.58
Fibonacci 38.2% 5.09
Last Price 4.14
52-Week Low 3.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar